We can't wait to host this year's #Science2Startup, where eight presenters from leading global academic institutions will present their startup ideas to fellow #biotech investors and industry executives. To learn more about the event or get involved, email us at info@science2startup.com or visit www.science2startup.com.
RA Capital Management’s Post
More Relevant Posts
-
Our iBIO NewsBrief is on break for the Holidays, but I can’t resist sharing this great article in Crain's Chicago Business by Steven A. Gould, M.D. "For startup founders, this is the classic dilemma" : https://lnkd.in/gz-KfTUd Exciting scientific discoveries don't always come with a solid plan for funding a potential startup. Crafting a compelling story and identifying critical milestones are key, but don't forget to factor in the funding environment and the time it takes to complete the next raise. Check out the Crains article for more insights on how to deliver cutting-edge scientific discoveries to the world. #startupfunding #biotech #scienceventure #innovation https://lnkd.in/gz-KfTUd
To view or add a comment, sign in
-
-
QMB works with companies within life sciences to help them navigate the often complex regulatory landscape. Startup accelerators present a wonderful opportunity to engage and provide critical guidance to future innovators. Michel E. Moravia, MSE, MBA will be leading a regulatory workshop at Northeastern University's Evolve Accelerator on February 27th. If you are a life sciences accelerator or venture studio, please reach out and let us know if you would like to collaborate on something similar. #lifesciences #meddevice #regulatorystrategy #regulatoryaffairs Christopher Wallace Leonard Glatkowski Henry Kim
To view or add a comment, sign in
-
In the ever-evolving landscape of the biotech industry, resilience and adaptability are paramount for startups seeking long-term success. Join us on October 18th at MIT for a discussion on Biotech Innovation: Scaling for Success. Learn about funding, commercialization, and IP strategies from industry experts, Katherine Rubino, Christine Cole, Christina J. Ansted, MPH, CCMEP and Kristen Park Hopson. In collaboration with MIT Sandbox, this panel will be moderated by Jinane Abounadi. Register now to reserve your seat. 🔗 Link in the comments. #BiotechEntrepreneur #StartupSuccess #StrategicInsights
To view or add a comment, sign in
-
The journey from #incubator to your first list sciences space can be complex and challenging, but it doesn't have to be. Discover how to find the right space for your #biotech startup. https://bit.ly/3FHO6Fu #JLLlifesciences #startup
To view or add a comment, sign in
-
"While Europe has science on the mind, there is an insufficient number of VCs with a background in science or technology, who can do proper due diligence on startups working on deep science.” An insightful read on Sifted emphasizes the need to train the next generation of deeptech investors. At Obloo Ventures we firmly believe this is key to successful funding decisions. How do we translate this? - 70% of our investment team holds a PhD - We've pioneered the EMBAIN master course in Innovation with MIB Trieste School of Management. - We're actively engaged in the upcoming #DIGI-ME, an international education program centered on multi-application digital technologies, uniting research centers, science parks, innovation hubs, venture capitalists, and SMEs. Promoting tech transfer means getting more ideas from the lab to the market, but also enabling scientists to become investors or deep tech entrepreneurs. Thanks Cristina Gallardo for the valuable read and eager to keep the discussion going! #Obloo #OblooVentures #Deepscover #Sifted #VentureCapital #deeptech #ScientistVCs
To view or add a comment, sign in
-
-
Yesterday, I had the pleasure of catching up with a former colleague, who already onto her second startup – truly inspiring! We discussed the main challenges startups are facing these days (hint: it’s not all about the money… although it is still remain a huge challenge). We also highlighted the necessity of an effective 𝗴𝗿𝗼𝘄𝘁𝗵 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝘆 that encompasses not only product development but also the production phase - a critical factor that can make or break your venture. Naturally, our conversation turned to the value of Bio-DFM. She totally gets it - "…𝗜𝘁'𝘀 𝗮𝗹𝗹 𝗮𝗯𝗼𝘂𝘁 𝗱𝗲𝘀𝗶𝗴𝗻𝗶𝗻𝗴 𝗯𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝘀 𝘄𝗶𝘁𝗵 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗶𝗻 𝗺𝗶𝗻𝗱 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝘃𝗲𝗿𝘆 𝗯𝗲𝗴𝗶𝗻𝗻𝗶𝗻𝗴…" Spot on! Eventually, the Bio-DFM approach (represented by Bio-D4M) not only reduces production costs but also enhances efficiency and elevates product quality…. It bridges the gap between innovation and production, ensuring innovations are designed with manufacturability in mind from the get-go. It helps bring groundbreaking biotech products to market more efficiently. Here’s to innovation, friendship, and the exciting future of biotech! 🥂 #BioDFM #Biotechnology #Innovation #Manufacturability #bioinnovation #medtech
To view or add a comment, sign in
-
-
Want to learn how to navigate negotiations and conflict resolution as a biotech or life science startup? This is a skill for any founder at any stage. Join us with Jeremy Lack of Lawtech as he shares his insights and learnings in today's Lunch & Learn. Open to all! Join us at 1PM. Register here: https://lnkd.in/efyRZ8_S #legaladvice #cancertech #founderadvice #lunchandlearn #webinar #healthtech #medtech
To view or add a comment, sign in
-
-
F-Prime Capital is honored to once again co-host the #Science2Startup symposium, alongside others from the biotech investment community, to identify promising science and technologies with startup potential. F-Prime's Jessica Alston, Ph.D., will serve as an advisor for the event. "S2S is more than an event; It's a beacon for innovation where top scientists worldwide come together to present their ideas and interact with leading investors and executives in Boston's established biotech ecosystem," said Dr. Alston. "Our goal is to nurture our connections while supporting the translation of scientific breakthroughs to solve the greatest challenges in #healthcare and medicine." Learn more about this unique opportunity for scientists, entrepreneurs, #biotech operators, and investor to meet, collaborate and translate exciting ideas into real innovations: www.science2startup.com
To view or add a comment, sign in
-
-
Thank you Carina Clingman, PhD, Alison Hall, and Recruitomics Consulting for such an engaging conversation. I can't believe we covered so much ground in a short period of time. Thank you for also giving me the opportunity to talk about Target2Drug BioAdvisory and how it advises startups in the therapeutics space to make right strategic decisions in a capital-constrained environment. You gals are the best podcast interview duo ever! #startup #biotech #advisory
Biotech startups are some of the best places to be 💊 🤔 But are they more likely to need advice in the formative early years? And if so, when is the best time to bring in an advisor? In this episode, we’re joined by Songsong “David” Cao (PhD, MBA), Founder of Target2Drug BioAdvisory, to discuss the difference between a biotech advisory and a consulting firm; the joys of working with startups; when to bring biotech advisors in; and how Target2Drug came to be! 🎧 Click the link in the comments to listen to the full episode (and remember to subscribe!) 👇 #biotech #biotechrecruitment #buildingbiotechs
To view or add a comment, sign in
-
Get the 🍿 ready for a terrific new series debuting on 7/1/24 from LabCentral! Great conversations between CEO Johannes Fruehauf and biotech founders in each episode. If #lifesciences and #biotech are your domain, you won't want to miss!
🫣 Sneak peek below! 🫣 LabCentral is thrilled to introduce our new video series, ‘The Dish with Johannes' features LabCentral’s President and Executive Director, Johannes Fruehauf, as he deep dives into the dynamic world of biotech. Just as a petri dish cultivates growth and #innovation, ‘The Dish with Johannes’ spotlights the stories at the heart of Cambridge's vibrant #biotech culture. From the inception of groundbreaking #startups to the strategic decisions of #investors and the unwavering support of #industryleaders, ‘The Dish with Johannes’ offers a front-row seat to the stories that shape the future of biotech. Tune in to hear the next wave of biotech pioneers dish out their insight.
To view or add a comment, sign in